Document:

September 4, 2018 Exhibit 10.2

    EXHIBIT 10.2

VOTING AGREEMENT

THIS VOTING AGREEMENT (this "Agreement") is entered into as of September 5, 2018, by and among the investors listed
on Schedule A hereto (each, an "Investor" and collectively, the "Investors"), S&W Seed Company, a Nevada corporation
(the "Company"), and the stockholders of the Company listed on Schedule B hereto (each, a "Stockholder" and collectively, the
"Stockholders"). Capitalized terms used herein but not otherwise defined shall have the meaning given to them in the Purchase Agreement (as defined below).

BACKGROUND

A.  The execution and delivery of this Agreement by the Stockholders is a material inducement to the willingness of the Investors to enter into that certain
Securities Purchase Agreement, dated as of the date hereof (the "Purchase Agreement"), by and among the Company and the Investors, pursuant to which, subject
to the terms and conditions set forth in the Purchase Agreement, the Investors will purchase Shares.

B.  Each Stockholder understands and acknowledges that the Company and Investors are entitled to rely on (i) the truth and accuracy of Stockholder's
representations contained herein and (ii) Stockholder's performance of the obligations set forth herein.

In consideration of the promises and the covenants and agreements set forth in the Purchase Agreement and in this Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

1. Shares Subject to this Agreement; Transfer Restrictions.

(a)The Stockholders each agree to hold all shares of voting capital stock of the Company registered in their respective names or beneficially owned by them and/or
over which they exercise voting control as of the date of this Agreement and any other shares of voting capital stock of the Company legally or beneficially held or acquired by them after the
date hereof or over which they exercise voting control (the "Shares") subject to, and to vote the Shares in accordance with, the provisions of this Agreement.

(b) Until the termination of this Agreement, or unless the transferee agrees to be bound by the terms of this Agreement, the Stockholder covenants and agrees that
the Stockholder will not directly or indirectly, (i) sell, assign, transfer (including by merger or operation of law), pledge, encumber or otherwise dispose of any of the Shares,
(ii) deposit any of the Shares into a voting trust or enter into a voting agreement or arrangement with respect to the Shares or grant any proxy or power of attorney with respect thereto
which is inconsistent with this Agreement or (iii) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect sale, assignment, transfer
(including by merger or operation of law) or other disposition of any Shares. The Company shall not recognize the transfer of any Shares in violation of the transfer restrictions set forth in this
Section 2(b).

2. Agreement to Vote Shares.

(a) In any annual, special or adjourned meeting of the stockholders of the Company, and in every written consent in lieu of any such meeting, at which the
transactions contemplated by the Purchase Agreement are presented to the Company's stockholders for approval, each Stockholder agrees that it will vote, by proxy or otherwise, its Shares
(i) in favor of the transactions contemplated by the Purchase

                                                        -1-

Agreement and any matter that would reasonably be expected to facilitate such transactions, and (ii) against approval
of any proposal made in opposition to the transactions contemplated by the Purchase Agreement. Each Stockholder shall retain at all times the right to vote its Shares in its sole discretion and
without any other limitation on those matters other than those set forth in clauses (i) and (ii) of this Section 2(a) that are at any time or from time to time presented for
consideration to the Company's stockholders generally.

(b) Notwithstanding the foregoing, nothing in this Agreement shall limit or restrict a Stockholder from acting in such Stockholder's capacity as a director or officer of
the Company, to the extent applicable, it being understood that this Agreement shall apply to a Stockholder solely in such Stockholder's capacity as a stockholder of the Company.

(c) In the event that a meeting of the stockholders of the Company is held, each Stockholder shall, or shall cause the holder of record on any applicable record date
to, appear at such meeting or otherwise cause such Stockholder's Shares to be counted as present thereat for purposes of establishing a quorum.

(d) Irrevocable Proxy.

(i)Each Stockholder hereby irrevocably grants to and appoints, and hereby authorizes and empowers, the Company, and any individual designated in writing by it,
and each of them individually, as such Stockholder's sole and exclusive proxy and attorney-in-fact (with full power of substitution and resubstitution), for and in the Stockholder's name, place
and stead, to vote and exercise all voting and related rights (to the fullest extent that the Stockholder is entitled to do so) with respect to its Shares at any meeting of the stockholders of the
Company called, and in every written consent in lieu of such meeting, with respect to any of the matters specified in, and in accordance and consistent with, clauses (i) and (ii) of
Section 2(a) of this Agreement. Such Stockholder may freely vote its Shares on all other matters not contemplated by clauses (i) and (ii) of Section 2(a) of this
Agreement.

(ii)Each Stockholder understands and acknowledges that the Investors and the Company are entering into the Purchase Agreement in reliance upon the
Stockholder's execution and delivery of this Agreement. Each Stockholder hereby affirms that the irrevocable proxy set forth in this Section 2(d) constitutes an inducement for the
Investors and the Company to enter into the Purchase Agreement. Except as otherwise provided for herein, the Stockholder hereby (a) affirms that the irrevocable proxy is coupled with
an interest and may under no circumstances be revoked; (b) ratifies and confirms that the proxies appointed hereunder may lawfully do or cause to be done by virtue hereof; and
(c) affirms that such irrevocable proxy is executed and intended to be irrevocable in accordance with the provisions of Section 78.355 of the Nevada Revised Statutes.

(iii)Upon the execution of this Agreement by the Stockholder, the Stockholder hereby revokes any and all prior proxies or powers of attorney given by the
Stockholder with respect to the Shares. The Stockholder acknowledges and agrees that no subsequent proxies with respect to such Shares shall be given, and if given, shall not be effective.
All authority conferred herein shall be binding upon and enforceable against any successors or assigns of the Stockholder and any transferees of the Shares. Notwithstanding any other
provisions of this Agreement, the irrevocable proxy granted hereunder shall automatically terminate upon the termination of this Agreement in accordance with Section 6(m) of this Agreement.

3. Representations, Warranties and Other Covenants of Stockholder. Each Stockholder, as to itself and not with respect to any other Stockholder,
hereby represents, warrants and covenants to the Company as follows:

                                                        -2-

(a)Such Stockholder is the legal or beneficial owner of, and has the power to vote that number of issued and outstanding Shares set forth on the signature page
hereto. Such Shares are owned free of any encumbrance that would preclude Stockholder from exercising his, her or its voting power as provided in Section 2 of this
Agreement or otherwise complying with the terms hereof.

(b)Such Stockholder has all requisite power, legal capacity and authority to enter into this Agreement. This Agreement has been duly executed and delivered by
Stockholder and, assuming the due authorization, execution and delivery of this Agreement by the Company, constitutes a valid and binding obligation of Stockholder, enforceable against
Stockholder in accordance with its terms, except as limited by (a) applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting
enforcement of creditors' rights generally, and (b) laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

(c)The execution, delivery and performance of this Agreement by such Stockholder will not (i) conflict with, require a consent, waiver or approval under, or
result in a breach of or default under, any of the terms of any agreement to which Stockholder is a party or by which any of such Stockholder's assets are bound or (ii) violate any order,
writ, injunction, decree, judgment or any applicable law applicable to such Stockholder or any of its assets, except for any such conflict, violation or any failure to obtain such consent, waiver or
approval that would not result in such Stockholder being able to perform its obligations under this Agreement.

(d)Such Stockholder agrees that it will not, in its capacity as a stockholder of the Company, bring, commence, institute, maintain, prosecute or voluntarily aid any
action, claim, suit or cause of action, in law or in equity, in any court or before any governmental entity, which (i) challenges the validity of or seeks to enjoin the operation of any provision
of this Agreement or (ii) alleges that the execution and delivery of this Agreement by such Stockholder, or the approval of the Purchase Agreement by the Company's Board of Directors
(the "Board"), breaches any fiduciary duty of the Board or any member thereof.

(e)Such Stockholder shall not, directly or indirectly, take any action that would make any representation or warranty contained herein untrue or incorrect in any
material respects or in any way have the effect of restricting, limiting, interfering with, preventing or disabling such Stockholder from performing his, her or its obligations in any material respects
under this Agreement.

4. Confidentiality. Except as required by applicable law, each Stockholder, until such time as the transactions contemplated by the Purchase
Agreement are publicly disclosed by the Company in compliance with the Purchase Agreement, will maintain the confidentiality of any information regarding this Agreement, the Purchase
Agreement and the transactions contemplated thereby. Neither each Stockholder, nor any of his, her or its respective Affiliates shall issue or cause the publication of any press release or other
public announcement with respect to this Agreement, the Purchase Agreement or the transactions contemplated thereby without the prior written consent of the Company, except as may be
required by law or by any listing agreement with, or the policies of, The Nasdaq Stock Market LLC, in which circumstance such announcing party shall make all reasonable efforts to consult
with the Company in advance of such publication to the extent practicable.

5. No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in the Company any direct or indirect ownership or
incidence of ownership of or with respect to any Shares.

                                                        -3-

6. Miscellaneous.

(a) Notices. All notices, requests, and other communications hereunder shall be in writing and will be deemed to have been duly given and received
(a) when personally delivered, (b) when sent by facsimile or email upon confirmation of receipt, (c) one business day after the day on which the same has been delivered
prepaid to a nationally recognized courier service, or (d) five business days after the deposit in the United States mail, registered or certified, return receipt requested, postage prepaid, in
each case addressed, as to the Company, to:

S&W Seed Company

                   106 K Street, Suite 300

                   Sacramento, California 95814

                   Attn: Matthew K. Szot

                   Facsimile: (559) 884-2750 

                   Email: mszot@swseedco.com

and as to any Stockholder, at the address and facsimile number set forth below such Stockholder's signature on the signature pages of this Agreement. Any party hereto
from time to time may change its address, facsimile number, or other information for the purpose of notices to that party by giving notice specifying such change to the other parties hereto.
Each Stockholder and the Company may each agree in writing to accept notices and other communications to it hereunder by electronic communications pursuant to procedures reasonably
approved by it; provided that approval of such procedures may be limited to particular notices or communications.

(b) Interpretation. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. The words "include," "includes" and "including" when used herein shall be deemed in each case to be followed by the words
"without limitation." The phrases "the date of this Agreement," "the date hereof," and terms of similar import, unless the context otherwise requires, shall be
deemed to refer to the date first above written. Unless the context of this Agreement otherwise requires: (i) words of any gender include each other gender; (ii) words using the
singular or plural number also include the plural or singular number, respectively; and (iii) the terms "hereof," "herein," "hereunder" and derivative or
similar words refer to this entire Agreement.

(c) Amendments; Waiver. This Agreement may be amended by the parties hereto, and the terms and conditions hereof may be waived, only by an
instrument in writing and signed by (i) the Company, (ii) the Investors holding a majority of the then-outstanding Shares issued pursuant to the Purchase Agreement and (iii) the Stockholders
holding a majority of the then-outstanding Shares. The failure of either party hereto to exercise any right, power or remedy provided under this Agreement or otherwise available in respect of
this Agreement at law or in equity, or to insist upon compliance by any other party with its obligation under this Agreement, and any custom or practice of the parties at variance with the terms
of this Agreement, shall not constitute a waiver by such party of such party's right to exercise any such or other right, power or remedy or to demand such compliance.

(d) Rules of Construction. The parties hereto hereby waive the application of any law, regulation, holding or rule of construction providing that
ambiguities in an agreement or other document will be construed against the party drafting such agreement or document.

(e) Specific Performance; Injunctive Relief. The parties hereto agree that the Company will be irreparably harmed and that there will be no adequate
remedy at law for a violation of any of the covenants or agreements of any Stockholder set forth herein. Therefore, it is agreed that, in addition to

                                                        -4-

any other remedies that may be available to
the Company upon any such violation of this Agreement, the Company and the Investors shall have the right to enforce such covenants and agreements by specific performance, injunctive
relief or by any other means available to the Company or the

Investors at law or in equity and each Stockholder hereby waives any and all defenses which could exist in its favor in connection with such enforcement and waives any
requirement for the security or posting of any bond in connection with such enforcement.

(f) Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same instrument and
shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties hereto; it being understood that all parties need not sign the
same counterpart.

(g) Entire Agreement; Nonassignability; Parties in Interest; Death or Incapacity. This Agreement and the documents and instruments and other
agreements specifically referred to herein or delivered pursuant hereto (i) constitute an inducement and condition to the Investors entering into the Purchase Agreement,
(ii) constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, among the
parties with respect to the subject matter hereof and (iii) are not intended to confer, and shall not be construed as conferring, upon any person other than the parties hereto any rights or
remedies hereunder. Neither this Agreement nor any of the rights, interests, or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or
otherwise, by each Stockholder without the prior written consent of the Company, and any such assignment or delegation that is not consented to shall be null and void. This Agreement,
together with any rights, interests or obligations of the Company hereunder, may be assigned or delegated in whole or in part by the Company to any affiliate of the Company without the
consent of or any action by Stockholder upon notice by the Company to Stockholder as herein provided. Subject to the preceding sentence, this Agreement shall be binding upon, inure to the
benefit of, and be enforceable by, the parties hereto and their respective permitted successors and assigns. All authority conferred herein shall survive the death or incapacity of the
Stockholder and in the event of Stockholder's death or incapacity, any obligation of the Stockholder hereunder shall be binding upon the heirs, personal representatives, successors and
assigns of the Stockholder.

(h) Additional Documents. Stockholder shall execute and deliver any additional documents necessary or desirable in the reasonable opinion of the
Company to carry out the purpose and intent of this Agreement.

(i) Severability. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent
jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement shall continue in full force and effect and the application of such provision to other persons or circumstances
shall be interpreted so as reasonably to effect the intent of the parties hereto. The parties hereto further agree to use their commercially reasonable efforts to replace such void or unenforceable
provision of this Agreement with a valid and enforceable provision that shall achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable
provision.

(j) Remedies Cumulative. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party shall be deemed
cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy shall not preclude the exercise of
any other remedy.

                                                        -5-

(k) Governing Law; Consent to Jurisdiction. This Agreement, and the provisions, rights, obligations, and conditions set forth herein, and the legal
relations between the parties hereto, including all disputes and claims, whether arising in contract, tort, or under statute, shall be governed by and construed in accordance with the laws of the
State of New York without giving effect to its conflict of law provisions.

(l) Expenses. All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party
incurring the expenses.

(m) Termination. This Agreement shall terminate and shall have no further force or effect from and after the earlier to occur of (i) date upon
which the stockholders of the Company, in any annual, special or adjourned meeting of the stockholders of the Company, or by written consent in lieu of any such meeting, approve the
transactions contemplated by the Purchase Agreement, (ii) the termination of the Purchase Agreement in accordance with its terms and (iii) August 31, 2019, and thereafter there
shall be no liability or obligation on the part of the Stockholders, provided, that no such termination shall relieve any party from liability for any willful or intentional breach of this
Agreement prior to such termination.

(n) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY
PARTY HERETO IN NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

   

   

   

                                                        -6-

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first written above.

COMPANY:

S&W SEED COMPANY

 

By:/s/ Matthew K. Szot

        Matthew K. Szot

        Executive Vice President of Finance and

        Administration and Chief Financial Officer

 

   

   

   

                                                        -7-

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first written above.

INVESTOR:

MFP Partners, L.P.

By: MFP Investors LLC,

           Its General Partner

    

By:/s/ Ellen Lynch

        Ellen Lynch

        Chief Financial Officer

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first written above.

STOCKHOLDER:

David A. Fischhoff, Ph.D.

/s/ David A. Fischhoff, Ph.D.

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

5,447
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Mark J. Harvey

/s/ Mark J. Harvey

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

234,925
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Consuelo E. Madere

/s/ Consuelo E. Madere

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

0
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Alexander C. Matina

/s/ Alexander C. Matina

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

6,316
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Charles B. Seidler

/s/ Charles B. Seidler

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

63,105
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Robert D. Straus

/s/ Robert D. Straus

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

0
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Grover T. Wickersham

/s/ Grover T. Wickersham

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

240,2001
 shares of issued and outstanding Common Stock

   

   

   

1 Includes 23,723 shares held by RWL Management, Inc.

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Alan Willits

/s/ Alan Willits

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

0
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Mark W. Wong

/s/ Mark W. Wong

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

90,745
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Matthew K. Szot

/s/ Matthew K. Szot

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

75,131
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Dennis C. Jury

/s/ Dennis C. Jury

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

246,505
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

Danielson B. Gardner

/s/ Danielson B. Gardner

          (signature)

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

3,225
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDER:

MFP Partners, L.P.

By: MFP Investors LLC,

         Its General Partner

By:  /s/ Ellen Lynch   

          Ellen Lynch

          Chief Financial Officer

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:

7,102,300
 shares of issued and outstanding Common Stock

   

   

   

IN WITNESS WHEREOF, the parties hereto have caused this VOTING AGREEMENT to be executed as of the date first
written above.

STOCKHOLDERS:

Wynnefield Partners Small Cap Value, LP I

 

	
By:
	
/s/ Robert D. Straus 

	
Name:
	
Robert D. Straus 

	
Title:
	
   

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:
2,159,2851
 shares of issued and outstanding Common Stock

Wynnefield Partners Small Cap Value, LP

 

	
By:
	
/s/ Robert D. Straus 

	
Name:
	
Robert D. Straus 

	
Title:
	
   

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:
1,482,809
 shares of issued and outstanding Common Stock

Wynnefield Small Cap Value Offshore Fund Ltd.

 

	
By:
	
/s/ Robert D. Straus 

	
Name:
	
Robert D. Straus 

	
Title:
	
   

Shares owned beneficially or of record by the Stockholder, or over which the Stockholder exercises voting power on the date hereof:
580,241
 shares of issued and outstanding Common Stock

1Includes 129,235 shares held by Wynnefield Capital, Inc. Profit Sharing Plan

Schedule A

SCHEDULE OF INVESTORS

MFP Partners, L.P.

   c/o MFP Investors LLC

   909 Third Avenue, 3rd Floor

   New York, NY 10022 

   Attention: Timothy E. Ladin

   Fax: (212) 752-7265

   Email: tladin@mfpllc.com

   

   

   

Schedule B

 

SCHEDULE OF STOCKHOLDERS

	
David A. Fischhoff, Ph.D. 

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Danielson B. Gardner

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Mark J. Harvey

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Dennis C. Jury

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Consuelo E. Madere

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Alexander C. Matina

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Charles B. Seidler

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Robert D. Straus

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Matthew K. Szot

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Grover T. Wickersham

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Alan Willits

   106 K Street, Suite 300

   Sacramento CA, 95814

	
Mark W. Wong

   106 K Street, Suite 300

   Sacramento CA, 95814

	
MFP Partners, L.P.

   c/o MFP Investors LLC

   909 Third Avenue, 3rd Floor

   New York, NY 10022 

   Attention: Timothy E. Ladin

   Fax: (212) 752-7265

   Email: tladin@mfpllc.com

	
Wynnefield Partners Small Cap Value, LP I

   Wynnefield Capital, Inc.

   450 Seventh Avenue, Suite 509

   New York, NY 10123

   Attention: Alex Liu; Stephen Zelkowicz

   Fax: 212-760-0824

   Email: aliu@wynnecap.com; szelkowicz@wynnecap.com

	
Wynnefield Partners Small Cap Value, LP

   Wynnefield Capital, Inc.

   450 Seventh Avenue, Suite 509

   New York, NY 10123

   Attention: Alex Liu; Stephen Zelkowicz

   Fax: 212-760-0824

   Email: aliu@wynnecap.com; szelkowicz@wynnecap.com

	
Wynnefield Small Cap Value Offshore Fund Ltd.

   Wynnefield Capital, Inc.

   450 Seventh Avenue, Suite 509

   New York, NY 10123

   Attention: Alex Liu; Stephen Zelkowicz

   Fax: 212-760-0824

   Email: aliu@wynnecap.com; szelkowicz@wynnecap.comSeptember 4, 2018 Exhibit 10.3

    EXHIBIT 10.3

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), is made and entered into effective as of September 5, 2018, by and
among S&W Seed Company, a Nevada corporation (the "Company") and the investors listed on Exhibit A hereto (each, an
"Investor" and together the "Investors").

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Investors (the "Purchase Agreement") in connection with the following.

W I T N E S S E T H

WHEREAS, the Company and the Investors have entered into the Purchase Agreement providing for the offer and sale of 1,607,717
shares of the Company's Common Stock (the "Common Shares") and 7,235 shares of the Company's Series A Convertible Preferred Stock (the "Preferred
Shares" and together with the Common Shares, the "Shares") in a private placement exempt from the registration requirements of the Securities Act of 1933, as
amended (the "Securities Act"), pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D promulgated thereunder; and

WHEREAS, as an inducement to the Investors to purchase the Shares, the Company has agreed to provide the Investors with certain registration rights.

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement and for good and valuable consideration, the receipt of which
is hereby acknowledged, the parties to this Agreement agree as follows:

ARTICLE I

CERTAIN DEFINITIONS

For purposes of this Agreement, the following terms shall have the following meanings:

(a)   The term "Affiliate" means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with,
such Person; provided that, for the purposes of this definition, "control" (including, with correlative meanings, the terms "controlled by" and "under common control
with"), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by contract or otherwise.

(b)   The term "Business Day" means each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York
City are generally authorized or obligated by law or executive order to close.

(c)   The term "Board" means the Board of Directors of the Company.

(d)   The term "Commission" means the United States Securities and Exchange Commission or any successor agency.

(e)   The term "Conversion Shares" means the shares of the Company's Common Stock issuable upon conversion of the Preferred Shares.

(f)   The term "Exchange Act" means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

(g)   The term "Person" (but not "person") means any individual, firm, corporation, partnership, limited liability company, trust or other entity, and
shall include any successor (by merger or otherwise) of such entity.

(h)   The term "Purchase Price" means $3,110 per Preferred Share.

(i)   The term "Securities Act" means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

Any terms used in this Agreement and not defined herein shall have the meanings given such terms in the Purchase Agreement.

ARTICLE II

REGISTRATION OF COMMON STOCK; INDEMNIFICATION

Section 2.01   Registrable Securities.  For the purposes of this Agreement, "Registrable Securities" means the Common Shares and the
Conversion Shares; provided that (i) the Common Shares and the Conversion Shares will cease to be Registrable Securities, and (ii) the Company will not be obligated to maintain the
effectiveness of the Resale Registration Statement (as defined below), and the Company's obligations under Section 2.02 hereof will cease, with respect to the Registrable Securities of a
holder thereof (a "Holder") following the date on which (a) such securities have been sold or otherwise transferred by the Holder thereof pursuant to an effective registration
statement; or (b) such securities are sold in accordance with Rule 144 (or any successor provision) promulgated under the Securities Act.  The period of time during which the Company is
required to keep the Resale Registration Statement effective is referred to as the "Effectiveness Period." 

Section 2.02   Registration.  Within seventy-five (75) Business Days following the date on which the Preferred Shares are first issued to the Investors (the "Filing
Date"), the Company shall prepare and file a resale registration statement on Form S-3 or another applicable form, if Form S-3 is not then available, registering offers and sales of
Registrable Securities held by the Investors and any other Holders of Registrable Securities pursuant to Rule 415 under the Securities Act (such registration
statement together with all exhibits thereto and any post-effective amendment thereto that becomes effective, the "Resale Registration Statement").  The Company may
supplement the Resale Registration Statement from time to time to register securities other than Registrable Securities for sale for the account of any

                                                   2

Person; provided, however, that such supplement will be permitted only so long as the Commission rules provide that such supplement does not give the
Commission the right to review the Resale Registration Statement; provided, further, that such supplement does not adversely affect the rights of any Holder. 
Notwithstanding the foregoing or anything to the contrary in this Article II, if the Company grants registration rights to one or more other holders of its Common Stock that are more favorable to
such holders than the registration rights granted hereunder, with respect to underwritten offerings or otherwise, the Company and the holders of a majority of the Registrable Securities
hereunder shall in good faith amend this Agreement to reflect such more favorable terms as reasonably as practicable.

Section 2.03   Registration  Procedures. In connection with the registration of any Registrable Securities under the Securities Act as provided in this Article II, the Company
will use its best efforts to:

(a)   cause the Resale Registration Statement (and any other related registrations, qualifications or compliances as may be reasonably requested and as would permit or
facilitate the sale and distribution of all Registrable Securities until the distribution thereof is complete) to become effective as soon as practicable following the filing thereof but not later than
180 days after the Filing Date (the "Scheduled Effective Date");

(b)   prepare and file with the Commission the amendments and supplements to the Resale Registration Statement and the prospectus used in connection therewith and
take all other actions as may be necessary to keep the Resale Registration Statement continuously effective until the disposition of all securities in accordance with the intended methods of
disposition by the Holder or Holders thereof set forth in the Resale Registration Statement will be completed, and to comply with the provisions of the Securities Act (to the extent applicable to
the Company) with respect to the dispositions;

(c)   (i) at least five (5) Business Days before filing with the Commission, furnish to each Holder and its counsel (if any) copies of all documents proposed to be filed with
the Commission in connection with such registration, which documents will be subject to the review and reasonable comment of such Holder and its counsel; (ii) furnish to each Holder of
Registrable Securities a reasonable number of copies of the Resale Registration Statement, of each amendment and supplement thereto, and of the prospectus included in the Resale
Registration Statement (including each preliminary prospectus), in conformity with the requirements of the Securities Act, and the other documents (including exhibits to any of the foregoing),
as the Holder may reasonably request, in order to facilitate the disposition of the Registrable Securities owned by such Holder; (iii) respond as promptly as practicable to any comments
received from the Commission with respect to each Resale Registration Statement or any amendment thereto; and (iv), as promptly as reasonably possible, provide the Holders true and
complete copies of all correspondence from and to the Commission relating to such Resale Registration Statement that pertains to the Holders as "Selling Stockholders" but not any
comments that would result in the disclosure to the Holders of material and non-public information concerning the Company.

                                                   3

(d)   register or qualify the Registrable Securities covered by the Resale Registration Statement under the securities or "blue sky" laws of the various states
as any Holder reasonably requests and do any and all other acts and things that may be necessary or reasonably advisable to enable a Holder to consummate the disposition in such states of
the Registrable Securities owned by such Holder, except that the Company will not be required to qualify generally to do business as a foreign corporation in any jurisdiction wherein it would
not, but for the requirements of this Section 2.03(d), be obligated to be qualified, or to subject itself to taxation in any jurisdiction;

(e)   provide a transfer agent and registrar for the Registrable Securities covered by the Resale Registration Statement not later than the effective date of the Resale
Registration Statement; 

(f)   notify the Holders promptly, and confirm such notice in writing, (i)(A) when a prospectus as contained in the Resale Registration Statement (a
"Prospectus") or any Prospectus supplement or post-effective amendment has been filed, and (B) with respect to a Resale Registration Statement or any post-effective
amendment, when the same has become effective, (ii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of
a Resale Registration Statement or the initiation of any proceedings for that purpose, (iii) of the receipt by the Company of any notification with respect to the suspension of the qualification or
exemption from qualification of any of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, (iv) of the existence of any fact or
the happening of any event that makes any statement made in such Resale Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein
by reference untrue in any material respect or which requires the making of any changes in such Resale Registration Statement, Prospectus or documents so that, in the case of the Resale
Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not
misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, (v) of the Company's reasonable determination that a post-effective amendment to a Resale
Registration Statement would be appropriate, or (vi) of any request by the Commission or other governmental authority for amendments or supplements to a Resale Registration Statement or
related Prospectus or for additional information that pertains to the Holders as "Selling Stockholders" or the "Plan of Distribution;"  

(g)   enter into customary agreements (including, in the event the Holders elect to engage an underwriter in connection with the Resale Registration Statement, an
underwriting agreement containing customary terms and conditions) and take all other actions as may be reasonably required in order to expedite or facilitate the disposition of Registrable
Securities; provided, however, that the Company will not be liable for any underwriter's fees, commissions and discounts or similar expenses; and

(h)   make every reasonable effort to obtain the withdrawal of any order suspending the effectiveness of the Resale Registration Statement or any suspension of the
qualification of any of the Registrable Securities for sale in any jurisdiction, at the earliest possible time.

                                                   4

Section 2.04   Rule 144.  With a view to making available to the Holders the benefits of certain rules and regulations of the Commission that at any time permit the sale of
the Registrable Securities to the public without registration, the Company agrees to:

(a)   make and keep public information available, as those terms are understood and defined in Rule 144 promulgated under the Securities Act;

(b)   file with the Commission in a timely manner all reports and other documents required of the Company under the Exchange Act;

(c)   so long as a Holder owns any unregistered Registrable Securities, furnish to the Holder upon any reasonable request a written statement by the Company as to its
compliance with the public information requirements of Rule 144 promulgated under the Securities Act and/or the Exchange Act, a copy of the most recent annual or quarterly report of the
Company, and any other reports and documents of the Company as the Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell
any Registrable Securities without registration (excluding any reports or documents of the Company that the Company, in its sole discretion, deems confidential); provided, that to the extent
such documents and reports are available on the Commission's website, the Company shall not be required to provide the copies contemplated by this subsection (c); and

(d)   take such further action as any Holder may reasonably request to enable such Holder to sell the Registrable Securities without registration under the Securities Act
within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including providing any legal opinions relating to such sale pursuant to Rule 144.

Section 2.05   Registration and Selling Expenses.  All expenses incurred by the Company in connection with the Company's performance of or compliance with this Article
II, including, without limitation, (i) all Commission registration and filing fees, (ii) blue sky fees and expenses, (iii) all necessary printing and duplicating expenses and (iv) all fees and
disbursements of counsel and accountants retained on behalf of the Company, will be paid by the Company. Each Holder may, at its election, retain its own counsel and other representatives
and advisors as it chooses at its own expense; provided that the Company will pay the reasonable fees and expenses of one counsel to the Holders incurred as part of reviewing the
Resale Registration Statement and any Prospectuses and amendments related thereto, in an amount not to exceed $15,000 for each Holder during the term of this Agreement.

Section 2.06   Registration Statement Not Declared Effective. The Company and the Holders agree that the Holders will suffer damages if (i) the Resale Registration
Statement is not declared effective by the Commission on or prior to the Scheduled Effective Date, or (ii) the length or frequency of Black-Out Periods (as defined below) exceed the limits set
forth in Section 2.07(a) hereof. The Company and the Holders further agree that it would not be feasible to ascertain the extent of such damages with precision. Accordingly, (x) if the Resale
Registration Statement is not declared effective by the Commission on or prior to the Scheduled Effective Date and on such date or at any time thereafter the Company is not diligently and in
good faith making commercially reasonable efforts to have the Resale Registration Statement

                                                   5

declared effective, the Company shall pay an amount in cash as liquidated damages to each
Holder equal to one percent (1%) of the aggregate Purchase Price paid for the Shares by such Holder for each thirty (30) day period after the Scheduled Effective Date during which the
Company is failing to make such efforts, up to an aggregate maximum of four percent (4%); and (y) during the continuance of a Black-Out Period beyond the limits set forth in Section 2.07(a)
hereof, the Company shall pay an amount in cash as liquidated damages to each Holder equal to one percent (1%) of the aggregate Purchase Price paid for the Shares by such Holder for
each thirty (30) day period during the continuance of a Black-Out Period beyond such limits, pro-rated as applicable for any partial month, up to an aggregate maximum of four percent
(4%).

Section 2.07   Inability to Use Prospectus; Black-Out Periods.  Each Holder agrees that, upon receipt of any notice from the Company of (i) the happening of any event of
the kind described in Sections 2.03(f)(i)(A), 2.03(f)(ii), 2.03(f)(iii), 2.03(f)(iv), 2.03(f)(v) or 2.03(f)(vi) hereof, or (ii) a determination by the Board that it is advisable to suspend use
of the Prospectus for a discrete period of time due to pending corporate developments such as negotiation of a material transaction which the Company in its sole discretion after consultation
with legal counsel, determines it would be obligated to disclose in the Resale Registration Statement, which disclosure the Company believes would be premature or otherwise inadvisable at
such time or would have a material adverse effect on the Company and its stockholders, such Holder will forthwith discontinue disposition of such Registrable Securities pursuant to the Resale
Registration Statement or Prospectus until such Holder's receipt of the copies of the supplemented or amended Prospectus contemplated by Section 2.03(b) hereof, or until such Holder is
advised in writing by the Company that the use of the applicable Prospectus may be resumed and has received copies of any additional or supplemental filings that are incorporated or deemed
to be incorporated by reference in such Prospectus. The period of time in which the use of a Prospectus or Resale Registration Statement is so suspended shall be referred to as a
"Black-Out Period." The Company agrees to so advise such Holder promptly of the commencement and termination of any such Black-Out Period, and the Purchasers
agree to keep the fact of such Black-Out Period confidential. The Company shall not impose a Black-Out Period under this Section 2.07 for more than ninety (90) consecutive days and not
more than twice in any given twelve (12) month period; provided, that at least sixty (60) days must pass between Black-Out Periods and the total aggregate length of all Black-Out periods
within any twelve (12) month period shall not exceed one hundred and twenty (120) days. Notwithstanding the foregoing, the Company may suspend use of any Resale Registration Statement
if the Commission's rules and regulations prohibit the Company from maintaining the effectiveness of a Resale Registration Statement because its financial statements are stale at a time when
its fiscal year has ended or it has made an acquisition reportable under Item 2.01 of Form 8-K or any other similar situation until the Company's Form 10-K has been filed or a Form 8-K,
including any required pro forma or historical financial statements, has been filed, respectively (provided that the Company shall use its reasonable best efforts to cure any such situation as
soon as possible so that the Resale Registration Statement can be used at the earliest possible time). 

                                                   6

Section 2.08   Certain Obligations of Holders.

(a)   As a condition to the inclusion of its Registrable Securities in the Resale Registration Statement, each Holder will furnish to the Company the information regarding
the Holder as is legally required in connection with any registration, qualification or compliance referred to in this Article II.

(b)   Each Holder hereby covenants with the Company not to make any sale of the Registrable Securities pursuant to the Resale Registration Statement without
effectively causing the prospectus delivery requirements under the Securities Act to be satisfied.

(c)   Each Holder acknowledges and agrees that the Registrable Securities sold pursuant to the Resale Registration Statement are not transferable on the books of the
Company unless the stock certificate submitted to the transfer agent evidencing the Registrable Securities, if applicable, is accompanied by a certificate reasonably satisfactory to the Company
to the effect that (i) the Registrable Securities have been sold in accordance with this Agreement and the Resale Registration Statement and (ii) the requirement of delivering a current
prospectus has been satisfied.

(d)   Each Holder is hereby advised that the anti-manipulation provisions of Regulation M under the Exchange Act may apply to sales of the Registrable Securities
offered pursuant to the Resale Registration Statement and agrees not to take any action with respect to any distribution deemed to be made pursuant to the Resale Registration Statement that
constitutes a violation of Regulation M under the Exchange Act or any other applicable rule, regulation or law.

(e)   The rights to cause the Company to register Registrable Securities granted to the Holders by the Company under Section 2.02 hereof may be assigned in
whole or in part by a Holder in connection with the transfer of such Registrable Securities, provided, that: (i) the transfer of the Registrable Securities and the rights to register such Registrable
Securities are effected in accordance with applicable securities laws, (ii) the transfer involves not less than fifty percent (50%) of the Shares and the Conversion Shares (if any), (iii) the Holder
gives prior written notice to the Company, and (iv) the transferee agrees to comply with the terms and provisions of this Agreement in a written instrument reasonably satisfactory in form and
substance to the Company and its counsel. Except as specifically permitted by this Section 2.08, the rights of a Holder with respect to Registrable Securities will not be transferable to any other
Person, and any attempted transfer will cause all rights of the Holder to registration of Registrable Securities under this Article II to be forfeited, void ab initio and of no further force and
effect.

(f)   With the written consent of the Company and each Holder affected or potentially affected by such proposed waiver, any provision of Sections 2.01, 2.02, 2.03, 2.04,
2.05, 2.06, 2.07, 2.08 or 2.09 hereof may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely). Upon
the effectuation of each waiver, the Company will promptly give written notice thereof to such Holders.

                                                   7

Section 2.09   Indemnification.

(a)   By the Company.  The Company agrees to indemnify, to the fullest extent permitted by law, each Holder of Registrable Securities being sold, its directors,
officers, employees, members, managers, partners, agents, and each other Person, if any, who controls (within the meaning of the Securities Act and the rules and regulations thereunder)
such Holder (each, an "Indemnified Person") against all losses, claims, damages, liabilities, and expenses (including legal fees and expenses and all costs incident to
investigation or preparation with respect to such losses, claims, damages, liabilities, and expenses and to reimburse such Indemnified Person for such costs as incurred) (collectively, the
"Losses") caused by, resulting from, or relating to any untrue or alleged untrue statement of material fact contained in the Resale Registration Statement, prospectus, or
preliminary prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or a fact necessary to make the
statements therein not misleading, except insofar as the same are caused by or contained in any information furnished to the Company by or on behalf of such Holder in writing expressly for
use therein or by such Holder's failure to deliver a copy of the Resale Registration Statement or prospectus or any amendments or supplements thereto after the Company has furnished such
Holder with a sufficient number of copies of the same and notified such Holder of such obligation. In connection with an underwritten offering and without limiting any of the Company's other
obligations under this Agreement, the Company shall indemnify such underwriters, their officers, directors, employees, and agents and each Person who controls (within the meaning of the
Securities Act and the rules and regulations thereunder) such underwriters or such other indemnified Person to the same extent as provided above with respect to the indemnification of the
Holders of Registrable Securities being sold.

(b)   By the Investors.  In connection with any registration statement in which a Holder of Registrable Securities is participating
pursuant to this Agreement, each such Holder will, if requested, furnish to the Company in writing information regarding such Holder's ownership of Registrable Securities and, to the extent
permitted by law, shall, severally and not jointly, indemnify the Company, its directors, and each Person who controls (within the meaning of the Securities Act and the rules and regulations
thereunder) the Company against all Losses caused by, resulting from, or relating to any untrue or alleged untrue statement of material fact contained in the Resale Registration Statement,
prospectus, or preliminary prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to
make the statements therein not misleading, but only to the extent that such untrue statement or omission is caused by and contained in such information so furnished to the Company in
writing by or on behalf of such Holder expressly for use therein; provided, however, that each Holder's obligation to indemnify the Company hereunder shall be apportioned
between each Holder based upon the net amount received by each Holder from the sale of Registrable Securities, as compared to the total net amount received by all of the Holders of
Registrable Securities sold pursuant to such registration statement, no such Holder being liable to the Company in excess of such apportionment; and provided, further that
each Holder's obligation to indemnify the Company hereunder shall be apportioned between each Holder as is appropriate to reflect the relative fault of such Holder on the one hand, and of
each other Holder on the other, in connection with the statements or omissions that resulted in such Losses. The relative fault of each Holder on the one hand, and each other Holder on the
other, shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by such Holder and the parties' relevant intent, knowledge, information and opportunity to correct or prevent such statement or omission.

                                                   8

(c)   Notice.  Any Person entitled to indemnification hereunder shall give prompt written notice to the indemnifying party of any claim with respect to which its
seeks indemnification; provided, however, that the failure to give such notice shall not release the indemnifying party from its obligation, except to the extent that the indemnifying party has
been materially prejudiced by such failure to provide such notice.

(d)   Defense of Actions.  In any case in which any such action is brought against any indemnified party, and it notifies an indemnifying party of the
commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly notified, to assume the
defense thereof, with counsel reasonably satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party will not (so long as it shall continue to have the right to defend, contest, litigate, and settle the matter in question in accordance with this paragraph) be liable to
such indemnified party hereunder for any legal or other expense subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of
investigation, supervision, and monitoring (unless such indemnified party reasonably objects to such assumption on the grounds that there may be defenses available to it that are different from
or in addition to the defenses available to such indemnifying party or if a conflict or potential conflict of interest exists, in either of which event the indemnified party shall be reimbursed by the
indemnifying party for the expenses incurred in connection with retaining separate legal counsel). An indemnifying party shall not be liable for any settlement of an action or claim effected
without its consent, which consent shall not be unreasonably withheld, conditioned or delayed. The indemnifying party shall lose its right to defend, contest, litigate and settle a matter if it shall
fail diligently to contest such matter (except to the extent settled in accordance with the next following sentence). No matter shall be settled by an indemnifying party without the consent of the
indemnified party (which consent shall not be unreasonably withheld, conditioned or delayed). The indemnifying party shall not, without the prior written consent of an indemnified party (which
consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement of any pending or threatened proceedings in respect of which indemnity has been sought hereunder
by such indemnified party unless (i) such settlement includes an unconditional release of such indemnified party in form and substance satisfactory to such indemnified party from all liability on
the claims that are the subject matter of such proceedings and (ii) such settlement does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of
any indemnified party.

(e)   Jointly Indemnifiable Claims.  Given that an Indemnified Person may be entitled to indemnification (a "Jointly Indemnifiable Claim") from
both the Company, pursuant to this Agreement, and from any other Person, whether pursuant to applicable law, any indemnification agreement, the organizational documents of such Person or
otherwise (the "Indemnitee-Related Entities"), the Company acknowledges and agrees that the Company shall be fully and primarily responsible for the payment to the
Indemnified Person in respect of indemnification and advancement of expenses in connection with any such Jointly Indemnifiable Claim, pursuant to and in accordance with the terms of this
Agreement, irrespective of any right of recovery the Indemnified Person may have from the Indemnitee-Related Entities. Under no circumstance shall the Company be entitled to any right of
subrogation or contribution by the Indemnitee-Related Entities and no right of recovery the Indemnified Person may have from the

                                                   9

Indemnitee-Related Entities shall reduce or otherwise alter
the rights of the Indemnified Person or the obligations of the Company hereunder. In the event that any of the Indemnitee-Related Entities shall make any payment to the Indemnified Person in
respect of indemnification or advancement of expenses with respect to any Jointly Indemnifiable Claim, the Indemnitee-Related Entity making such payment shall be subrogated to the extent of
such payment to all of the rights of recovery of the Indemnified Person against the Company, and the Indemnified Person shall execute all papers reasonably required and shall do all things
that may be reasonably necessary to secure such rights, including the execution of such documents as may be necessary to enable the Indemnitee-Related Entities effectively to bring suit to
enforce such rights. Each of the Indemnitee-Related Entities shall be third-party beneficiaries with respect to this Section 2.09(e), entitled to enforce this Section 2.09(e)
against the Company as though each such Indemnitee-Related Entity were a party to this Agreement.

(f)    Survival.  The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of
the indemnified Person and will survive the transfer of the Registrable Securities and the termination of this Agreement.

(g)   Contribution.  If recovery is not available under the foregoing indemnification provisions for any reason or reasons other than as specified therein, any
Person who would otherwise be entitled to indemnification by the terms thereof shall nevertheless be entitled to contribution with respect to any Losses with respect to which such Person would
be entitled to such indemnification but for such reason or reasons. In determining the amount of contribution to which the respective Persons are entitled, there shall be considered the Persons'
relative knowledge and access to information concerning the matter with respect to which the claim was asserted, the opportunity to correct and prevent any statement or omission, and other
equitable considerations appropriate under the circumstances, including the relative fault of such Person, in connection with the statements or omissions that resulted in Losses. The relative
fault of each Person shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by such Person and the parties' relevant intent, knowledge, information and opportunity to correct or prevent such statement or omission. It is
hereby agreed that it would not necessarily be equitable if the amount of such contribution were determined by pro rata or per capita allocation. No Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
Notwithstanding the foregoing, each Investor and any Affiliate of any such Investor shall not be required to make a
contribution in excess of the net amount received by such Investor (or its Affiliate) from the sale of Registrable Securities.  

ARTICLE III

MISCELLANEOUS

Section 3.01   Inconsistent Agreements.  Without the prior written consent of the Investors holding a majority of the then-outstanding Registrable Securities, the Company shall

                                                   10

not enter into any registration rights agreement that conflicts, or is inconsistent, with the provisions of Article II hereof.

Section 3.02   Specific Performance.  Each Investor and the Company acknowledge and agree that, in the event of any breach of this Agreement, the non-breaching party
or parties would be irreparably harmed and could not be made whole by monetary damages. Each Investor and the Company hereby agree that, in addition to
any other remedy to which any Investor may be entitled at law or in equity, each such Investor shall be entitled to compel
specific performance of this Agreement in any action instituted in any court of the United States or any state thereof having subject matter jurisdiction for such action.

Section 3.03   Headings.  The headings in this Agreement are for convenience of reference only and shall not control or affect the meaning or construction of any
provisions hereof.

Section 3.04   Entire Agreement.  Except for the Purchase Agreement, this Agreement (a) constitutes the entire agreement and understanding of the parties hereto in
respect of the subject matter contained herein, and there are no restrictions, promises, representations, warranties, covenants, conditions, or undertakings with respect to the subject matter
hereof, other than those expressly set forth or referred to herein, and (b) amends and supersedes all prior agreements and understandings between the parties hereto with respect to the
subject matter hereof.

Section 3.05   Notices.  All notices and other communications hereunder shall be in writing and shall be delivered personally, by next-day courier, by electronic or facsimile
transmission, or telecopied with confirmation of receipt to the parties at the addresses specified below (or at such other address for a party as shall be specified by like notice; provided that
notices of change of address shall be effective only upon receipt thereof). Any such notice shall be effective upon receipt, if personally delivered, delivered by electronic or facsimile
transmission, or telecopied, or one day after delivery to a courier for next-day delivery.

If to the Company, to:

S&W Seed Company

106 K Street, Suite 300 

Sacramento, California 95814

Attention: Matthew K. Szot, Chief Financial Officer

Facsimile: (559) 884-2750

Email: mszot@swseedco.com 

If to an Investor or a Holder(s), to:

The address set forth under such Investor's or Holder's name on Exhibit A attached hereto.

                                                   11

Section 3.06   Applicable Law.  The substantive laws of the State of New York shall govern the interpretation, validity, and performance of the terms of this Agreement,
regardless of the law that might be applied under applicable principles of conflicts of laws.

Section 3.07   Severability.  The invalidity, illegality, or unenforceability of one or more of the provisions of this Agreement in any jurisdiction shall not affect the validity,
legality, or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality, or enforceability of this Agreement, including any such provision, in any other jurisdiction,
it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.

Section 3.08   Successors; Assigns.  The provisions of this Agreement shall be binding upon the parties hereto and their respective heirs,
successors, and permitted assigns, including, without limitation and without the need for an express assignment or assumption, any successor in interest to an Investor, whether by a sale of all
or substantially all of its assets, merger, consolidation, or otherwise. Neither this Agreement nor the rights or obligations of any party hereunder may be assigned, except as otherwise provided
in this Agreement.  Any such attempted assignment in contravention of this Agreement shall be void and of no effect.

Section 3.09   No Third-Party Beneficiaries.  Nothing in this Agreement creates in any Person not a party to this Agreement (other than permitted assignees and a Person
indemnified pursuant to Section 2.09 hereof with respect to such indemnification rights and any Holders of the Registrable Securities with respect to the rights to which they are entitled
hereunder) any legal or equitable right, remedy or claim under this Agreement, and this Agreement is for the exclusive benefit of the parties hereto.

Section 3.10   Amendments.  This Agreement may not be amended, modified, or supplemented unless such modification is in writing and signed by the Company and the
Investors holding a majority of the then-outstanding Registrable Securities.

Section 3.11   Waiver.  Any waiver (express or implied) of any default or breach of this Agreement shall not constitute a waiver of any other or subsequent default or
breach.

Section 3.12   Counterparts.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall constitute one
and the same Agreement.

[SIGNATURE PAGE FOLLOWS]

                                                   12

IN WITNESS WHEREOF, the undersigned hereby agrees to be bound by the terms and provisions of this Registration Rights Agreement as of the date first above written.

S&W SEED COMPANY

 

 

By:/s/ Matthew K. Szot

        Matthew K. Szot

        Executive Vice President of Finance and

        Administration and Chief Financial Officer

 

   

   

   

 [SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

IN WITNESS WHEREOF, the undersigned hereby agrees to be bound by the terms and provisions of this Registration Rights Agreement as of the date first above written.

INVESTOR:

MFP Partners, L.P.

By: MFP Investors LLC,

           Its General Partner

   

      By:/s/ Ellen Lynch 

           Ellen Lynch 

           Chief Financial Officer

   

   

   

 [SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

Exhibit A

INVESTORS

 

	
Name and Address

	
MFP Partners, L.P.

c/o MFP Investors LLC

   909 Third Avenue, 3rd Floor

   New York, NY 10022 

   Attention: Timothy E. Ladin

   Fax: (212) 752-7265

   Email: tladin@mfpllc.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]